Latest news
Loading news…
Ankekang Biopharmaceutical
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Chengdu, Sichuan, China Founded 2018 For Profit
Ankekang Biopharmaceutical develops innovative cancer therapies using Flavivirus tech, with full R&D to production chain.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
- IT spend
- $9M
Company Info
- Founded
- 2018
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- HQ
- Chengdu, Sichuan, China
- Region
- Asia-Pacific (APAC)
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -1.2
- Trend (90d)
- -1.9
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Ankekang Biopharmaceutical
Loading news…
FAQs about Ankekang Biopharmaceutical
People who checked this page also checked these
Browse the full Acquirezy directory.